Physician profile
Jeremy Yoder
NPI 1740761709
$1,395.28
in general payments reported to CMS, 2019-2025
9 companies · $38.32 in 2025
The $38.32 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $450 · 2024: $907 · 2025: $38.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,328 · Education: $66.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,328.29 |
| Education | $66.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $534.98 | 2023-2025 | Linq II, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Amgen INC. | $168.40 | 2023-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $157.32 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $134.75 | 2023-2024 | Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $109.69 | 2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.40 | 2023-2024 | Jardiance |
| Pfizer INC. | $78.56 | 2023-2024 | |
| Actelion Pharmaceuticals US, INC. | $66.99 | 2024 | Uptravi, Opsumit |
| Abbott Laboratories | $37.19 | 2024-2025 | Assurity, Jot Dx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Yoder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.